Skip to content

Steven M. Albert

4 papers in the library · 11 citations · publishing 2011-2025

Papers

Sort Most recent Most cited

A qualitative analysis of participant expectations and experiences of psilocybin‐assisted psychotherapy for methamphetamine use disorder

Addiction December 22, 2025 Jonathan Brett, Toby Lea, Elizabeth Knock et al.

Abstract Background and aims There is an urgent unmet need for novel treatments for methamphetamine (MA) use disorder. We explored the qualitative experiences of people participating in a study of psilocybin‐assisted psychotherapy (PAT) to treat MA use disorder. Design and setting Qualitative study of participants enrolled in a single arm, open‐label pilot study of PAT for MA use disorder...

DOI: 10.1111/add.70284 (opens in new tab) Qualitative research Qualitative analysis Interpersonal communication Focus group +7

Psilocybin‐assisted psychotherapy for methamphetamine use disorder: A pilot open‐label safety and feasibility study

Addiction September 20, 2025 Elizabeth Knock, Krista J. Siefried, Gillinder Bedi et al. 4 citations

Abstract Background & Aims There are few effective treatments for methamphetamine use disorder, despite increasing global demand. Here, we assessed the safety and feasibility of outpatient psilocybin‐assisted psychotherapy for methamphetamine use disorder. Design Single arm, open label pilot study. Setting Outpatient public stimulant treatment program at St. Vincent's Hospital, Sydney,...

Psilocybin-assisted psychotherapy for methamphetamine dependence: a case report involving daily methamphetamine use

Frontiers in Psychiatry December 6, 2024 Jonathan Brett, Elizabeth Knock, Kathy Watson et al. 7 citations

Methamphetamine (MA) dependence leads to severe physical and psychological issues. Current treatments, including psychosocial therapies and residential rehabilitation, face limitations such as high relapse rates, cost, and accessibility issues. As a result, there is an urgent need for novel approaches to treat MA dependence that are effective, affordable, and accessible to patients. Psilocybin,...

DOI: 10.3389/fpsyt.2024.1490907 (opens in new tab) Psilocybin Methamphetamine Hallucinogen Psychotherapist +1

The design and methods of the aging successfully with pain study.

Contemporary Clinical Trials November 15, 2011 Natalia E. Morone, Carol M. Greco, Bruce L Rollman et al.

Chronic low back pain (CLBP) is widespread among older adults (≥ 65 years) and is often treated inadequately. With a rapidly growing aging population, CLBP will increase and so will the demand for treatment. We believe that mind-body therapies can help to meet this demand. We present the methodology of a randomized, controlled clinical trial of 300 individuals with CLBP aged 65 years or older....